Long-term visual outcome and prognostic factors after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy

American Journal of Ophthalmology

Volumn 156, Issue 4, 2013, Pages

  Kang, Hae Min ^a   Koh, Hyoung Jun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

AGED; ARTICLE; CATARACT; CENTRAL RETINAL THICKNESS; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CYST FLUID; ENDOPHTHALMITIS; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INTRAOCULAR PRESSURE ABNORMALITY; MALE; METAMORPHOSIS; MONOTHERAPY; ONSET AGE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RETINA DETACHMENT; RETINA TEAR; RETROSPECTIVE STUDY; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL ACUITY CHART; VISUAL IMPAIRMENT;

EID: 84884595838     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.05.038     Document Type: Article

References (37)

1. L.A. Yannuzzi, J. Sorenson, R.F. Spaide, and B. Lipson Idiopathic polypoidal choroidal vasculopathy (IPCV) Retina 10 1 1990 1 8 (Pubitemid 20201879)
2. R.F. Spaide, L.A. Yannuzzi, J.S. Slakter, J. Sorenson, and D.A. Orlach Indocyanine green videoangiography of idiopathic choroidal vasculopathy Retina 15 2 1995 100 110
3. L.A. Yannuzzi, A. Ciardella, R.F. Spaide, M. Rabb, K.B. Freund, and D.A. Orlack The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy Arch Ophthalmol 115 4 1997 478 485 (Pubitemid 27172703)
4. L.A. Yannuzzi, D.W. Wong, and B.S. Sforzolini Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration Arch Ophthalmol 117 11 1999 1503 1510 (Pubitemid 29536478)
5. F. Gomi, and Y. Tano Polypoidal choroidal vasculopathy and treatments Curr Opin Ophthalmol 199 3 2008 208 212 (Pubitemid 351535916)
6. A. Koh, T.H. Lim, and K.G. Au Eong Optimizing the management of choroidal neovascularization in Asian patients: consensus on treatment recommendations for anti-VEGF therapy Singapore Med J 52 4 2011 232 240
7. J.P. Tong, W.M. Chan, and D.T. Liu Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization Am J Ophthalmol 141 3 2006 456 462 (Pubitemid 43265948)
8. H. Nakashizuka, M. Mitsumata, and S. Okisaka Clinicopathologic findings in polypoidal choroidal vasculopathy Invest Ophthalmol Vis Sci 49 11 2008 4729 4737
9. Y. Hirami, A. Tsujikawa, and A. Otani Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy Retina 27 3 2007 335 341 (Pubitemid 46398898)
10. T. Hikichi, M. Higuchi, and T. Matsushita One-year results of three monthly ranibizumab injections and as-needed reinjections for polypoidal choroidal vasculopathy in Japanese patients Am J Ophthalmol 154 1 2012 117 124
11. M. Saito, T. Iida, and M. Kano Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation Retina 31 8 2011 1589 1597
12. C.K. Cheng, C.H. Peng, C.K. Chang, C.C. Hu, and L.J. Chen One-year outcomes of intravitreal bevacizumab (Avastin) therapy for polypoidal choroidal vasculopathy Retina 31 5 2011 846 856
13. K. Yamashiro, K. Tomita, and A. Tsujikawa Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment Am J Ophthalmol 154 1 2012 125 136
14. T. Hikichi, H. Ohtsuka, and M. Higuchi Improvement of angiographic findings of polypoidal choroidal vasculopathy after initravitreal injection of ranibizumab monthly for 3 months Am J Ophthalmol 150 5 2010 674 682
15. H.M. Kang, Y.M. Kim, and H.J. Koh Five-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 155 3 2013 438 447
16. T. Hikichi, H. Ohtsuka, and M. Higuchi Factors predictive of visual acuity outcomes 1 year after photodynamic therapy in Japanese patients with polypoidal choroidal vasculopathy Retina 31 5 2011 857 865
17. A. Tsujikawa, Y. Ojima, and K. Yamashiro Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy Am J Ophthalmol 151 6 2011 961 972
18. P. Cackett, D. Wong, and I. Yeo A classification system for polypoidal choroidal vasculopathy Retina 29 2 2009 187 191
19. D.M. Marcus, H. Singh, M.N. Lott, J. Singh, and M.D. Marcus Intravitreal ranibizumab for polypoidal choroidal vasculopathy in non-Asian patients Retina 33 1 2013 35 47
20. T. Wakabayashi, F. Gomi, M. Sawa, M. Tsujikawa, and K. Nishida Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy Br J Ophthalmol 96 3 2012 394 399
21. C. Cursiefen, L. Chen, and L.P. Borges VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment J Clin Invest 113 7 2004 1040 1050 (Pubitemid 38544126)
22. B.A. Lafaut, S. Aisenbrey, and C. van den Broecke Polypoidal choroidal vasculopathy pattern in age-related macular degeneration. A clinicopathologic correlation Retina 20 6 2000 650 654 (Pubitemid 32427983)
23. A. Okubo, M. Sameshima, and A. Uemura Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study Br J Ophthalmol 86 10 2002 1093 1098
24. D.W. Leung, G. Cachianes, and W.J. Kuang Vascular endothelial growth factor is a scereted angiogenic mitogen Science 246 4935 1989 1306 1309 (Pubitemid 20066716)
25. G. Bergers, S. Song, N. Meyer-Morse, E. Bergsland, and D. Hanahan Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors J Clin Invest 111 9 2003 1287 1295 (Pubitemid 36554699)
26. A.N. Stangos, J.S. Gandhi, J. Nair-Sahni, H. Heimann, C.J. Pournaras, and S.P. Harding Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab Am J Ophthalmol 150 5 2010 666 673
27. W.R. Freeman, I. Kozak, R.M. Yuson, N. Nigam, L. Cheng, and F. Mojana Prognostic implications of pigment epithelial detachment in bevacizumab (Avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization Retina 31 9 2011 1812 1818
28. R.F. Spaide, F. Laude, and H.F. Fine Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration Retina 26 4 2006 383 390 (Pubitemid 44197628)
29. M. Bolz, S. Michels, W. Geitzenauer, F. Prager, and U. Schmidt-Erfurth Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment Br J Ophthalmol 91 6 2007 785 789 (Pubitemid 46846651)
30. M. Saito, T. Iida, and D. Nagayama Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment Br J Ophthalmol 92 12 2008 1642 1647
31. H. Koizumi, T. Yamagishi, T. Yamazaki, and S. Kinoshita Predictive factors of resolved retinal fluid after intravitreal ranibizumab for polypoidal choroidal vasculopathy Br J Ophthalmol 95 11 2011 1555 1559
32. F. Gomi, M. Ohji, and K. Sayanagi One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients Ophthalmology 115 1 2008 141 146 (Pubitemid 350309415)
33. W.M. Chan, D.S. Lam, and T.Y. Lai Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy Ophthalmology 111 8 2004 1576 1584
34. E. Akaza, M. Yuzawa, Y. Matsumoto, S. Kashiwakura, K. Fujita, and R. Mori Role of photodynamic therapy in polypoidal choroidal vasculopathy Jpn J Ophthalmol 51 4 2007 270 277 (Pubitemid 47174610)
35. R.M. Silva, J. Figueira, M.L. Cachulo, L. Duarte, J.R. Faria de Abreu, and J.G. Cunha-Vaz Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Graefes Arch Clin Ophthalmol 243 10 2005 973 979 (Pubitemid 41631036)
36. A. Yamashita, F. Shiraga, C. Shiragami, Y. Shirakata, and A. Fujiwara Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 155 1 2013 96 102
37. M. Sagong, S. Lim, and W. Chang Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy Am J Ophthalmol 153 5 2012 873 882